Skip to content
Politically.com Search all
Menu

South Dakota 2026

HB 1169

classify medetomidine as a Schedule III controlled substance and establish permissible uses.

Source: Open States / PluralLatest available (refresh delayed). Last refreshed: 2026-11-08 08:11:14 UTC.

Official record

Measure details

Jurisdiction
South Dakota
Session
2026
Chamber
lower
Classification
bill
Subjects
Controlled Substances, Public Health and Safety
Introduced / first action
2026-01-28 00:00:00

Sponsors

Source-supplied history

Actions

  1. Signed by the Governor on 2026-03-09 H.J. 534

    executive-signature
  2. Delivered to the Governor on 2026-03-04 H.J. 497

    executive-receipt
  3. Signed by the President S.J. 448

    passage
  4. Signed by the Speaker H.J. 477

    passage
  5. Senate Do Pass , Passed, YEAS 32, NAYS 0 S.J. 412

    passage
  6. Certified uncontested, placed on consent , Passed, S.J. 21

  7. Health and Human Services Do Pass , Passed, YEAS 7, NAYS 0 S.J. 21

    committee-passage
  8. Scheduled for hearing S.J. 1

  9. First read in Senate and referred to Senate Health and Human Services S.J. 260

    introduction, reading-1, referral-committee
  10. House of Representatives Do Pass , Passed, YEAS 63, NAYS 3 H.J. 295

    passage
  11. Certified uncontested, placed on consent , Passed,

  12. Health and Human Services Do Pass , Passed, YEAS 11, NAYS 0

    committee-passage
  13. Scheduled for hearing

  14. First read in House and referred to House Health and Human Services H.J. 163

    introduction, reading-1, referral-committee

When supplied by the API

Related measures

No resolvable related measure is supplied.